Patents by Inventor Alf Sollevi

Alf Sollevi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Selective vasodilation by continuous adenosine infusion
    Patent number: 5731296
    Abstract: This invention is concerned with the use of adenosine as an agent for the treatment of human beings. More particularly, this invention is concerned with the administration of adenosine to human patients by continuous intravenous infusion for, inter alia, control of blood pressure, use as a selective vasodilator, decreasing pulmonary vascular resistance, treating acute pulmonary hypertension in conjunction with idiopathic respiratory distress syndrome, in diagnosing pulmonary hypertension in conjunction with cardiac septum defects, in percutaneous transluminal angioplasty (PTCA), in coronary thrombolysis (CTL) and in radionucleide scintography.
    Type: Grant
    Filed: March 15, 1993
    Date of Patent: March 24, 1998
    Assignee: Item Development AB
    Inventor: Alf Sollevi
  • Method of treating hyperexcited sensory nerve function
    Patent number: 5691318
    Abstract: The described invention relates to the treatment of hyperexcited sensory nerve functions, e.g., neuropathia in human subjects, comprising parenteral administration of an amount of an adenosine receptor agonist to said subjects. It is demonstrated that an adenosine receptor agonist can alleviate or normalize hyperexcited sensory nerve functions such as the perception of touch, temperature, vibration, pain, pressure and disturbances in other sensory functions.
    Type: Grant
    Filed: October 31, 1996
    Date of Patent: November 25, 1997
    Assignee: Item Development AB
    Inventor: Alf Sollevi
  • Method of treating pulmonary inflammation by continuous administration of an adenosine-containing solution
    Patent number: 5648341
    Abstract: The described invention relates to a method of treatment of a pulmonary inflammatory reaction brought about by e.g. bacteraemia, physical trauma or viral infection, with activation of polymorphonuclear white blood cells, said method comprising continuous intravenous infusion of adenosine at a rate effective for such treatment, preferably 2 to 50 .mu.g/ml/min, more preferably 5-20 .mu.g/kg/min in a central vein.
    Type: Grant
    Filed: October 28, 1993
    Date of Patent: July 15, 1997
    Assignee: Item Development AB
    Inventor: Alf Sollevi
  • Treating myocardial infarction by administration of a thrombolytic agent together with adenosine
    Patent number: 5534504
    Abstract: This invention is concerned with the use of adenosine as an agent for the treatment of human beings. More particularly, this invention is concerned with the administration of adenosine to human patients by continuous intravenous infusion for, inter alia, control of blood pressure, use as a selective vasodilator, decreasing pulmonary vascular resistance, treating acute pulmonary hypertension in conjunction with idiopathic respiratory distress syndrome, in diagnosing pulmonary hypertension in conjunction with cardiac septum defects, in percutaneous transluminal angioplasty (PTCA), in coronary thrombolysis (CTL) and in radionucleide scintography.
    Type: Grant
    Filed: December 21, 1994
    Date of Patent: July 9, 1996
    Assignee: Item Development
    Inventor: Alf Sollevi
  • Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty
    Patent number: 5449665
    Abstract: This invention is concerned with the use of adenosine as an agent for the treatment of human beings. More particularly, this invention is concerned with the administration of adenosine to human patients by continuous intravenous infusion for, inter alia, control of blood pressure, use as a selective vasodilator, decreasing pulmonary vascular resistance, treating acute pulmonary hypertension in conjunction with idiopathic respiratory distress syndrome, in diagnosing pulmonary hypertension in conjunction with cardiac septum defects, in percutaneous transluminal angioplasty (PTCA), in coronary thrombolysis (CTL) and in radionucleide scintography.
    Type: Grant
    Filed: December 15, 1993
    Date of Patent: September 12, 1995
    Assignee: Item Development Aktiebolag
    Inventor: Alf Sollevi
  • Continuous administration adenosine to increase myocardial blood flow
    Patent number: 5231086
    Abstract: This invention is concerned with the use of adenosine as an agent for the treatment of human beings. More particularly, this invention is concerned with the administration of adenosine to human patients by continuous intravenous infusion for, inter alia, control of blood pressure, use as a selective vasodilator, decreasing pulmonary vascular resistance, treating acute pulmonary hypertension in conjunction with idiopathic respiratory distress syndrome, in diagnosing pulmonary hypertension in conjunction with cardiac septum defects, in percutaneous transluminal angioplasty (PTCA), in coronary thrombolysis (CTL) and in radionucleide scintography.
    Type: Grant
    Filed: January 14, 1992
    Date of Patent: July 27, 1993
    Assignee: Item Development Aktiebolag
    Inventor: Alf Sollevi
  • Continuous administration of adenosine to reduce pulmonary vascular resistance
    Patent number: 5104859
    Abstract: This invention is concerned with the use of adenosine as an agent for the treatment of human beings. More particularly, this invention is concerned with the administration of adenosine to human patients by continuous intravenous infusion for, inter alia, control of blood pressure, use as a selective vasodilator, decreasing pulmonary vascular resistance, treating acute pulmonary hypertension in conjunction with idiopathic respiratory distress syndrome, in diagnosing pulmonary hypertension in conjunction with cardiac septum defects, in percutaneous transluminal angioplasty (PTCA), in coronary thrombolysis (CTL), and in radionucleide scintography.
    Type: Grant
    Filed: December 19, 1990
    Date of Patent: April 14, 1992
    Assignee: Solimedco Aktiebolag
    Inventor: Alf Sollevi